|Articles|January 24, 2012

Poll: Should Drug Companies Disclose Payments They Make to Doctors?

The Obama administration is considering requiring drug companies to disclose all payments they make to doctors. This would include funds for research, speaking engagements, consulting, entertainment, etc.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe

Related Content

Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD

Latest CME

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Poll: Should Drug Companies Disclose Payments They Make to Doctors?

Related Content

Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD

Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

Closing the STI screening and follow-up gap in pregnancy, with Damian Alagia, III, MD

HIV screening, PrEP counseling get stronger ACOG recommendation